Maharashtra Food and Drug Administration (FDA) on 1 May 2015 ordered to file a FIR against the Snapdeal, its CEO Kunal Bahl and Directors for allegedly selling prescription drugs online. Selling of drugs without prescription is a crime under the Drugs and Cosmetics Act, 1940.
The FIR was filed after FDA officer on an investigation found that Jasper Infotech Pvt. Ltd. entered into agreements with dealers across India to supply medicines offered or exhibited for sale on its website, snapdeal.com, and to collect the sale proceeds on their behalf.
The FDA found that 45 of the displayed drugs were with objectionable claims which contravened the provisions of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.
The FDA will be investigating other online shopping companies such as Flipkart and Amazon.
Now get latest Current Affairs on mobile, Download # 1 Current Affairs App
When: 1 May 2015
DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.